Spry Therapeutics - About the company
Spry Therapeutics is an unfunded company based in White Plains (United States), founded in 2018 by Bob Purdy. It operates as a Developer of a nanobarrier based pillow to prevent respiratory infections. Spry Therapeutics has not raised any funding yet. The company has 2101 active competitors, including 471 funded and 337 that have exited. Its top competitors include companies like Antheia, Transcenta and Akeso.
Company Details
Spry has developed a patented technology to prevent respiratory infections. The company has developed a filter to block pathogens such as bacteria, viruses, germs, allergens, and molds made of Pureshield fabric and sealed Safeweld seams to seal the barrier. The company has developed a pillow made of patented technology to prevent the accumulation and growth of the pathogens.
- Website
- sprytherapeutics.com
- Email ID
- *****@sprytx.com
Key Metrics
Founded Year
2018
Location
White Plains, United States
Stage
Unfunded
Ranked
207th among 2101 active competitors
Employee Count
36 as on Sep 30, 2026
Legal entities associated with Spry Therapeutics
Spry Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
NP CREATIVE CONSTRUCTION, INC. CIN: 5333882 , United States, Active | May 02, 2018 | - | - | - |
Sign up to download Spry Therapeutics' company profile
Spry Therapeutics's funding and investors
Spry Therapeutics has not raised any funding rounds yet.
Spry Therapeutics' founders and board of directors
Founder? Claim ProfileHere are the details of Spry Therapeutics' key team members:
- Bob Purdy: Co-Founder & CEO of Spry Therapeutics.
View details of Spry Therapeutics's Founder profiles and Board Members
Spry Therapeutics' employee count trend
Spry Therapeutics has 36 employees as of Sep 26. Here is Spry Therapeutics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Spry Therapeutics's Competitors and alternates
Top competitors of Spry Therapeutics include Antheia, Transcenta and Akeso. Here is the list of Top 10 competitors of Spry Therapeutics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
2nd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
3rd | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
4th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
5th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | 64/100 | |
6th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
7th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
8th | LifeMine Therapeutics 2016, Watertown (United States), Series E | Developer of novel drugs from fungi via genome mining and recombinant overexpression | $563M | 62/100 | |
9th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $364M | 62/100 | |
10th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
207th | Spry Therapeutics 2018, White Plains (United States), Unfunded | Developer of a nanobarrier based pillow to prevent respiratory infections | - | - | 43/100 |
Looking for more details on Spry Therapeutics's competitors? Click here to see the top ones
Spry Therapeutics's Investments and acquisitions
Spry Therapeutics has made no investments or acquisitions yet.
Reports related to Spry Therapeutics
Here is the latest report on Spry Therapeutics's sector:
News related to Spry Therapeutics
Media has covered Spry Therapeutics for 1 event in last 1 year, It was about company updates.
•
•
SPRY Therapeutics has raised USD 15 Million in fresh funding round by Flourish Ventures, Together Fund, Eight Roads, and F-prime CapitalEnablers•Oct 09, 2024•Spry Therapeutics, Flourish, Together, Eight Roads Ventures and 1 other
•
SPRY Enables Clinics to Improve Patient Care While Easing Operational Demands With Rehab Therapy’s First AI-Integrated EMRBusiness Wire•May 22, 2024•Spry Therapeutics
•
Spry Therapeutics Introduces the World's First “Clean and Green” Positioning Pillow for HealthcarePRWeb•Feb 15, 2023•Spry Therapeutics, Fiberpartner
•
Shores Global Teams with Spry Therapeutics to Provide Virus-blocking Soft Goods Onboard Cruise ShipsPRWeb•Jul 08, 2020•Shores, Spry Therapeutics
•
Spry Therapeutics Announces Soft-Surface Filter Technology to Combat Healthcare Acquired Infections and SuperbugsHealthcare Facilities Today•May 26, 2020•Spry Therapeutics
Are you a Founder ?
FAQs about Spry Therapeutics
Explore our recently published companies
- Unwritten Wines - Saint Helena based, 2014 founded, Unfunded company
- C - Koge based, 2008 founded, Unfunded company
- Fortune Pharma - Jammu based, 2017 founded, Unfunded company
- Marketing Team Go - Unfunded company
- RC3 Partners - Atlanta based, 2016 founded, Unfunded company
- Reset Learning - Unfunded company